Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103483267B reveals a high-yield one-pot synthesis for aryl imidazole salts, enabling cost reduction in pharma intermediate manufacturing and reliable supply chain scalability.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN111848322B reveals a novel resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel catalyst-free N-methylation using formic acid and triethylamine in DMSO. High yields, broad substrate scope, suitable for industrial scale-up of fine chemicals.
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives offering mild conditions and high selectivity for pharmaceutical supply chains.
Novel patent CN106317060B offers a safer, high-yield route for Conivaptan HCl. Reduces toxic reagents and enhances supply chain reliability for pharmaceutical manufacturers.
Novel patent CN116768904B enables high-purity intermediate production with mild conditions and substantial supply chain efficiency improvements for global pharmaceutical manufacturing partners seeking reliable sourcing.
Patent CN113735867B reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with significant cost and supply chain advantages.
Novel chiral phosphoric acid catalysis enables high-purity indoline pyrroles. Efficient synthesis reduces costs for anticancer pharmaceutical intermediates supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with scalable supply chain reliability and cost efficiency.
Patent CN114315563B reveals a regioselective hydrocarboxylation method using PdCl2 and formic acid. This process offers significant cost reduction and supply chain reliability for fine chemical intermediates.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN113620795B details a Rh-catalyzed C-H activation route to benzocycloheptenones. This method offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN112094220B reveals a copper-catalyzed route for high-purity indole sulfones, enabling cost-effective API intermediate manufacturing and streamlined supply chains.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.